Logo image of 0UB.DE

UBS GROUP AG-REG (0UB.DE) Stock Fundamental Analysis

Europe - FRA:0UB - CH0244767585 - Common Stock

35.08 EUR
+0.62 (+1.8%)
Last: 10/3/2025, 7:00:00 PM
Fundamental Rating

4

Overall 0UB gets a fundamental rating of 4 out of 10. We evaluated 0UB against 116 industry peers in the Capital Markets industry. 0UB has a bad profitability rating. Also its financial health evaluation is rather negative. 0UB has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

0UB had positive earnings in the past year.
In the past year 0UB had a positive cash flow from operations.
0UB had positive earnings in each of the past 5 years.
Each year in the past 5 years 0UB had a positive operating cash flow.
0UB.DE Yearly Net Income VS EBIT VS OCF VS FCF0UB.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B 60B 80B

1.2 Ratios

0UB's Return On Assets of 0.38% is in line compared to the rest of the industry. 0UB outperforms 43.10% of its industry peers.
0UB has a Return On Equity (7.04%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.38%
ROE 7.04%
ROIC N/A
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
0UB.DE Yearly ROA, ROE, ROIC0UB.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

0UB has a Profit Margin of 12.25%. This is comparable to the rest of the industry: 0UB outperforms 52.59% of its industry peers.
In the last couple of years the Profit Margin of 0UB has declined.
0UB does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 12.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
0UB.DE Yearly Profit, Operating, Gross Margins0UB.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

2

2. Health

2.1 Basic Checks

0UB has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, 0UB has less shares outstanding
0UB has a better debt/assets ratio than last year.
0UB.DE Yearly Shares Outstanding0UB.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B
0UB.DE Yearly Total Debt VS Total Assets0UB.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

0UB has a debt to FCF ratio of 37.17. This is a negative value and a sign of low solvency as 0UB would need 37.17 years to pay back of all of its debts.
0UB has a Debt to FCF ratio (37.17) which is comparable to the rest of the industry.
0UB has a Debt/Equity ratio of 4.21. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 0UB (4.21) is worse than 64.66% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.21
Debt/FCF 37.17
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
0UB.DE Yearly LT Debt VS Equity VS FCF0UB.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100B 200B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
0UB.DE Yearly Current Assets VS Current Liabilites0UB.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

6

3. Growth

3.1 Past

0UB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 256.60%, which is quite impressive.
0UB shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.99% yearly.
The Revenue has been growing slightly by 3.14% in the past year.
0UB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.83% yearly.
EPS 1Y (TTM)256.6%
EPS 3Y-9.49%
EPS 5Y3.99%
EPS Q2Q%111.76%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y11.11%
Revenue growth 5Y10.83%
Sales Q2Q%-3.74%

3.2 Future

The Earnings Per Share is expected to grow by 24.75% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 2.76% on average over the next years.
EPS Next Y51.91%
EPS Next 2Y45.48%
EPS Next 3Y39.61%
EPS Next 5Y24.75%
Revenue Next Year0%
Revenue Next 2Y1.6%
Revenue Next 3Y2.41%
Revenue Next 5Y2.76%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
0UB.DE Yearly Revenue VS Estimates0UB.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B 40B 50B
0UB.DE Yearly EPS VS Estimates0UB.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 21.79, the valuation of 0UB can be described as rather expensive.
64.66% of the companies in the same industry are more expensive than 0UB, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 0UB to the average of the S&P500 Index (27.86), we can say 0UB is valued slightly cheaper.
A Price/Forward Earnings ratio of 12.82 indicates a correct valuation of 0UB.
Based on the Price/Forward Earnings ratio, 0UB is valued cheaply inside the industry as 80.17% of the companies are valued more expensively.
0UB's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.32.
Industry RankSector Rank
PE 21.79
Fwd PE 12.82
0UB.DE Price Earnings VS Forward Price Earnings0UB.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, 0UB is valued cheaper than 81.03% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.63
EV/EBITDA N/A
0UB.DE Per share data0UB.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
0UB's earnings are expected to grow with 39.61% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.42
PEG (5Y)5.46
EPS Next 2Y45.48%
EPS Next 3Y39.61%

5

5. Dividend

5.1 Amount

0UB has a Yearly Dividend Yield of 2.22%.
Compared to an average industry Dividend Yield of 5.80, 0UB pays a bit more dividend than its industry peers.
0UB's Dividend Yield is comparable with the S&P500 average which is at 2.41.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of 0UB has a limited annual growth rate of 0.29%.
Dividend Growth(5Y)0.29%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

0UB pays out 45.62% of its income as dividend. This is a bit on the high side, but may be sustainable.
0UB's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.62%
EPS Next 2Y45.48%
EPS Next 3Y39.61%
0UB.DE Yearly Income VS Free CF VS Dividend0UB.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B -20B 40B -40B 60B 80B
0UB.DE Dividend Payout.0UB.DE Dividend Payout, showing the Payout Ratio.0UB.DE Dividend Payout.PayoutRetained Earnings

UBS GROUP AG-REG

FRA:0UB (10/3/2025, 7:00:00 PM)

35.08

+0.62 (+1.8%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners55.07%
Inst Owner ChangeN/A
Ins Owners0.04%
Ins Owner ChangeN/A
Market Cap117.22B
Analysts76.8
Price Target34.71 (-1.05%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.61
Dividend Growth(5Y)0.29%
DP45.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.02%
Min EPS beat(2)-4.5%
Max EPS beat(2)-1.54%
EPS beat(4)1
Avg EPS beat(4)-2.38%
Min EPS beat(4)-25.26%
Max EPS beat(4)21.79%
EPS beat(8)3
Avg EPS beat(8)-37.54%
EPS beat(12)5
Avg EPS beat(12)-32.43%
EPS beat(16)9
Avg EPS beat(16)-17.8%
Revenue beat(2)0
Avg Revenue beat(2)-4.89%
Min Revenue beat(2)-5.19%
Max Revenue beat(2)-4.59%
Revenue beat(4)1
Avg Revenue beat(4)-0.94%
Min Revenue beat(4)-5.19%
Max Revenue beat(4)8.05%
Revenue beat(8)5
Avg Revenue beat(8)3.05%
Revenue beat(12)9
Avg Revenue beat(12)3.85%
Revenue beat(16)13
Avg Revenue beat(16)5.74%
PT rev (1m)0.26%
PT rev (3m)10.17%
EPS NQ rev (1m)2.11%
EPS NQ rev (3m)-8.26%
EPS NY rev (1m)1.73%
EPS NY rev (3m)10.99%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)4.83%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)2.14%
Valuation
Industry RankSector Rank
PE 21.79
Fwd PE 12.82
P/S 2.69
P/FCF 13.63
P/OCF 11.19
P/B 1.54
P/tB 1.68
EV/EBITDA N/A
EPS(TTM)1.61
EY4.59%
EPS(NY)2.74
Fwd EY7.8%
FCF(TTM)2.57
FCFY7.33%
OCF(TTM)3.13
OCFY8.93%
SpS13.05
BVpS22.73
TBVpS20.94
PEG (NY)0.42
PEG (5Y)5.46
Profitability
Industry RankSector Rank
ROA 0.38%
ROE 7.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 12.25%
GM N/A
FCFM 19.71%
ROA(3y)0.87%
ROA(5y)0.77%
ROE(3y)17.12%
ROE(5y)14.94%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-20.78%
PM growth 5Y-6.71%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 4.21
Debt/FCF 37.17
Debt/EBITDA N/A
Cap/Depr 58.63%
Cap/Sales 4.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 160.87%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)59.2%
Cap/Depr(5y)70.42%
Cap/Sales(3y)4.12%
Cap/Sales(5y)4.52%
Profit Quality(3y)167.93%
Profit Quality(5y)287.17%
High Growth Momentum
Growth
EPS 1Y (TTM)256.6%
EPS 3Y-9.49%
EPS 5Y3.99%
EPS Q2Q%111.76%
EPS Next Y51.91%
EPS Next 2Y45.48%
EPS Next 3Y39.61%
EPS Next 5Y24.75%
Revenue 1Y (TTM)3.14%
Revenue growth 3Y11.11%
Revenue growth 5Y10.83%
Sales Q2Q%-3.74%
Revenue Next Year0%
Revenue Next 2Y1.6%
Revenue Next 3Y2.41%
Revenue Next 5Y2.76%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year16.43%
EBIT Next 3Y26.59%
EBIT Next 5YN/A
FCF growth 1Y-18.83%
FCF growth 3Y-64.98%
FCF growth 5Y-41.22%
OCF growth 1Y-13.08%
OCF growth 3Y-52.92%
OCF growth 5Y-30.14%